Ultra-central lung tumors: safety and efficacy of protracted stereotactic body radiotherapy

Volume: 60, Issue: 8, Pages: 1061 - 1068
Published: Jun 30, 2021
Abstract
Background For patients with early stage or medically inoperable lung cancer, stereotactic body radiotherapy (SBRT) is a general accepted and effective treatment option. The role of SBRT in ultra-central tumors remains controversial. The aim of this single-center retrospective analysis was to evaluate the safety and efficacy of protracted SBRT with 60 Gy in 12 fractions (with a biological effective dose (BED10) of 90–150 Gy) for patients with...
Paper Details
Title
Ultra-central lung tumors: safety and efficacy of protracted stereotactic body radiotherapy
Published Date
Jun 30, 2021
Volume
60
Issue
8
Pages
1061 - 1068
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.